Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study  by Agarwal, Anil K. et al.
ORIGINAL ARTICLE
Minimally invasive versus the conventional open surgical approach
of a radical cholecystectomy for gallbladder cancer: a retrospective
comparative study
Anil K. Agarwal1, Amit Javed1, Raja Kalayarasan1 & Puja Sakhuja2
1Department of Gastrointestinal Surgery, and 2Department of Pathology, GB Pant Hospital & MAM College, Delhi University, New Delhi, India
Abstract
Background: Laparoscopic surgery has traditionally been contraindicated for the management of gall
bladder cancer (GBC). This study was undertaken to determine the safety and feasibility of a laparo-
scopic radical cholecystectomy (LRC) for GBC and compare it with an open radical cholecystectomy
(ORC).
Methods: Retrospective analysis of primary GBC patients (with limited liver infiltration) and incidental
GBC (IGBC) patients (detected after a laparoscopic cholecystectomy) who underwent LRC between
June 2011 and October 2013. Patients who fulfilled the study criteria and underwent ORC during the
same period formed the control group.
Results: During the study period, 147 patients with GBC underwent a radical cholecystectomy. Of
these, 24 patients (primary GBC– 20, IGBC – 4) who underwent a LRC formed the study group (Group
A). Of the remaining 123 patients who underwent ORC, 46 matched patients formed the control group
(Group B). The median operating time was higher in Group A (270 versus 240 mins, P = 0.021) and the
median blood loss (ml) was lower (200 versus 275 ml, P = 0.034). The post-operative morbidity and
mortality were similar (P = 1.0). The pathological stage of the tumour in Group A was T1b (n = 1),
T2 (n = 11) and T3 (n = 8), respectively. The median lymph node yield was 10 (4–31) and was compara-
ble between the two groups (P = 0.642). During a median follow-up of 18 (6–34) months, 1 patient in
Group A and 3 in Group B developed recurrence. No patient developed a recurrence at a port site.
Conclusion: LRC is safe and feasible in selected patients with GBC, and the results were comparable
to ORC in this retrospective comparison.
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Introduction
Minimally invasive surgery in gall bladder cancer (GBC) has a
potential role in staging of the disease (staging laparoscopy),
palliative bypass in locally advanced or metastatic disease and
radical surgery for potentially curable disease.1–8 The benefits of
a staging laparoscopy have previously been documented and
been shown to prevent a non-therapeutic laparotomy in 23–62%
of patients.1 In patients with gastric outlet obstruction resulting
from metastatic disease, a laparoscopic gastrojejunostomy has
been shown to decrease post-operative hospital stay and time to
resume oral intake.2 Traditionally, curative laparoscopic surgery
has been contraindicated in patients with suspected GBC.9
Reports of tumour implantation after a laparoscopic cholecystec-
tomy for unsuspected GBC was the most important factor that
precluded widespread employment of a laparoscopy in the treat-
ment of GBC.10,11 Recently, however, a few studies have advo-
cated the use of a minimally invasive, laparoscopic approach.3–8
The majority of these series have either a small number of
patients or have included only early GBC.3–7 In the largest feasi-
bility study published to date, 18 patients with T1 and T2 GBC
underwent a cholecystectomy along with resection of a small
liver wedge and hepatoduodenal lymphadenectomy7.
This present study was undertaken to determine the safety
and feasibility of a laparoscopic radical cholecystectomy (LRC)
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in patients with the T1–3 primary and incidental GBC (IGBC)
and to compare the outcome with patients who underwent an
open radical cholecystectomy (ORC).
Methods
In a retrospective analysis of GBC patients operated at a
tertiary referral teaching hospital, (June 2011 and October
2013), all patients with suspected GBC, who did not have
evidence of metastatic disease on clinical examination, under-
went an ultrasound followed by dual phase computed tomog-
raphy (CT) of the abdomen. Patients with primary GBC with
either no or limited liver infiltration (on CT abdomen); and
IGBC patients (Stage T1b–T3) after a laparoscopic cholecystec-
tomy were considered for a LRC and or resection. Informed
consent was obtained and those who refused a laparoscopic
procedure were offered an open radical cholecystectomy. Other
exclusion criteria for LRC included extensive liver infiltration
on CT, extrahepatic adjacent organ involvement (biliary, duo-
denal, colonic, pancreatic), IGBC detected after an open chole-
cystectomy and any systemic illness which contraindicated a
laparoscopic procedure.
A laparoscopic radical cholecystectomy was performed using
five abdominal ports with the patient in a French (low lithot-
omy) position. The pneumoperitoneum was established using
an infra-umbilical port and a staging laparoscopy was performed
as previously described.1 In patients with no evidence of dissem-
inated disease on staging laparoscopy, additional ports were
placed: 5 mm right pararectal port below the right subcostal
region, 11 mm left pararectal port above the level of umbilicus,
5 mm left midclavicular port below the left subcostal region and
a 5 mm epigastric port.
Surgical technique for LRC
The patient was placed in the reverse trendelenberg position
with a left lateral tilt. Before proceeding with a radical resec-
tion, a routine sampling biopsy of the inter-aortocaval (IAC)
16b1 lymph nodes was done. For this sampling, duodenal
kocherization was performed using two left-sided working
ports to expose the IAC area adequately. Any enlarged lymph
nodes in the IAC region below the level of left renal vein were
excised and sent for frozen section examination. In the absence
of grossly enlarged lymph nodes, fibrofatty tissue from the
same anatomical location was excised and examined. The
surgical resection was abandoned if metastatic disease was
identified on the frozen section histopathological analysis.
In primary GBC patients with no IAC lymph node metasta-
sis, further dissection was performed to expose structures in
the hepatocystic triangle as is done during a standard laparo-
scopic cholecystectomy. The cystic artery was ligated and
divided. The cystic duct was double clipped and divided, and
the cystic duct margin was sent for the frozen section examina-
tion. The IGBC patients in whom the data on the cystic duct
margin was not available, a dissection was performed to locate
the cystic duct and the margin for the frozen section was sent
for examination. To avoid slippage of the clips and subsequent
bile spillage, Hem-o-lok clips (Weck Closure System;
Research Triangle Park, Durham, NC, USA) were preferred for
the cystic duct. A wedge of segment IVb, V was marked using
a hook cautery. To facilitate the marking and dissection at
the inferior surface of segments IVb and V, the right lobe of
the liver was retracted upwards without handling the tumour.
The liver parenchymal transection was performed using a com-
bination of a Harmonic ScalpelTM (Ethicon Endosurgery,
Cincinnati, OH, USA), LigasureTM (Valleylab, Boulder, CO,
USA) and an ultrasonic aspirator (CUSATM; Valleylab). Superfi-
cial liver transection was performed using the Harmonic Scal-
pelTM, whereas LigasureTM and CUSATM were preferred for the
deeper liver transection. The middle hepatic vein in the supe-
rior aspect of the gall bladder bed was subsequently clipped
and divided. The resected tumour specimen was placed in a
specimen retrieval bag and was temporarily placed away from
the operative field.
The extent of a lymphadenectomy included lymph nodal
dissection along the entire length of the hepatic artery from
the celiac axis to the level of its bifurcation into the right and
left hepatic arteries; dissection of the retropancreatic lymph
nodes, and lymph nodal clearance of the hepatoduodenal liga-
ment including pericholedochal and peri/retroportal lymph
nodes. A circumferential dissection of the hepatoduodenal liga-
ment was completed, and the entire lymph nodal tissue was
excised enbloc. In this fashion, a standard lymphadenectomy
(which includes clearance of nodes from the hepatoduodenal
ligament skeletonizing the vascular structures and the bile
ducts with clearance of nodes anterior and posterior to the
head of the pancreas and the hepatic artery till its origin from
the celiac axis) was completed. The entire specimen was placed
in a protective bag and was removed through a small perium-
bilical incision. After ensuring satisfactory hemostasis, a silastic
drain was placed in the right subhepatic space and the wound
was closed in layers. In patients who underwent an ORC, a
right subcostal incision was used as previously described.1 In
patients with IGBC, in addition to the radical cholecystectomy,
a full thickness excision of all port sites used for the initial
laparoscopic cholecystectomy was added.
Post-operative management and follow up
The post-operative complications were documented and the
bile leak was defined and graded according to the Interna-
tional study group of liver surgery guidelines.12 The follow-
up protocol included clinical examination, ultrasound
abdomen and serum tumour marker levels (CEA and CA
19-9) every 3 months for the initial 2 years and then every
6 months for the next 3 years. A dual phase CT abdomen
was performed in patients with suspicious findings on ultra-
sound abdomen.
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Statisical analysis
Patients who underwent a laparoscopic radical cholecystectomy
during the study period were analysed and compared with a
select group of matched patients who underwent an open radi-
cal cholecystectomy during the same period. Statistical analysis
was performed using statistical program GraphPad INSTAT
version 4 (GraphPad Software, Inc., La Jolla, CA, USA). The
mean and median values were compared using the Mann–
Whitney test. Proportions were compared using Fischer’s exact
test. A P-value of < 0.05 was considered statistically significant.
Results
During the 28-month study period, 147 patients with GBC
underwent a radical cholecystectomy. Of these, 24 patients
(primary GBC – 20, IGBC – 4) who underwent a laparoscopic
radical cholecystectomy formed the study group (Group A). Of
the remaining 123 patients who underwent an ORC, 46
matched patients who fulfilled the criteria used for LRC were
selected for comparison (Group B). The median age of patients
undergoing a LRC was 44 (21–61) years with a female-to-male
ratio of 2.6:1. Table 1 depicts the comparison of the two
groups. The demographic characteristics (age and gender) were
comparable between the two groups. The median operating
time (min) was higher in Group A as compared with Group B
(270 versus 240, P = 0.021), however, the median blood loss
(ml) was less (200 versus 275, P = 0.034). None of the patients
in either group had perforation of the gallbladder or bile
spillage during the radical cholecystectomy. There was no post-
operative mortality in either group. The post-operative
morbidity included Grade A (International study group of liver
surgery) bile leak (n = 5, Group A – 1 and Group B – 4), sub-
hepatic collection requiring single time aspiration (n = 2,
Group A – 1, Group B – 1), minor chyle leak which settled
with conservative treatment (n = 1, Group A), wound
dehiscence requiring secondary suturing (n = 1, Group B) and
post-operative pneumonia (n = 2, Group B). The incidence of
morbidity in Group A (3/24, 12.5%) was similar to that in
Group B (8/46, 17.4%; P = 0.737).
The pathological T stage of the resected specimen in primary
GBC patients in Group A was T1b in 1, T2 in 11 and T3 in 8
patients, respectively. The pathological T stage was comparable
between the two groups (Table 2). Of the 13 IGBC patients, 9
(Group A – 3, Group B – 6) did not have any residual tumour
in the GB fossa and 4 (Group A – 1, Group B – 3) had a
residual tumor in the GB fossa. The excised port sites were free
of tumour in all except 1 patient (Group B) who had tumour
deposits in the epigastric port site. The median (range) num-
ber of IAC lymph nodes sampled in Group A and B were
2 (1–3) and 2 (1–4), respectively, and all the sampled nodes
were negative for malignancy. The cystic duct margin was neg-
ative in all patients and all of them underwent a curative (R0)
Table 1 Comparison of clinicopathological features of patients who underwent a laparoscopic (Group A) and open (Group B) radical
cholecystectomy
Parameter Group A (n = 24) Group B (n = 46) P value
Demography
Age, median (range) 44 (21–61) 49 (23–70) 0.281
Sex ratio, female: male 2.6:1 3:1 0.848
Operative data
Duration of surgery in min, median (range) 270 (180–340) 240 (180–360) 0.021
Blood loss in ml, median (range) 200 (100–850) 275 (100–800) 0.034
Post-operative data
Hospital stay in days, median (range) 5 (3–16) 5 (3–17) 0.111
Morbidity, n (%) 3 (12.5) 8 (17.4) 0.737
Histopathology
Lymph node yield, median (range) [mean ( SD)]
Overall 10 (4–31) [12.5 ( 5.4)] 11 (5–26) [12.9 ( 5.4)] 0.642
Primary GBC 12 (6–31) [13.6 ( 4.8)] 12.5 (5–26) [13.9 (5.6)] 0.781
IGBC 5 (4–10) [5.5 ( 1.7)] 6 (5–10) [7.4 ( 1.9)] 0.146
Stage, n (%)
I 3 (12.5) 5 (10.9) 1.000
II 10 (41.7) 10 (21.7) 0.099
IIIA 6 (25.0) 13 (28.3) 1.000
IIIB 5 (20.8) 18 (39.1) 0.181
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resection. The median (range) [mean ( SD)] lymph node
yield in Group A: 10 (4–31) [12.5 ( 5.4)] was comparable to
Group B: 11 (5–26) [12.9 ( 5.4)]. The mean and median
lymph node yield was higher in primary GBC patients com-
pared with IGBC patients in both groups. Five patients in
Group A had a lymph node positive tumour. After a median
(range) follow-up of 18 months (6–34), 23/24 patients in
Group A and 43/46 patients in Group B were alive without
any evidence of recurrence. One patient in Group A with T3N0
(14 nodes resected) disease developed jaundice owing to nodal
recurrence at 14 months follow up. No patient developed
recurrence at a port site. Three patients in Group B developed
recurrence (nodal recurrence – 2, liver metastasis – 1) at 11,
13 and 16 months follow up, respectively. Of the 3 patients, 2
had T3N1 disease and 1 had T2N1 disease.
Discussion
The present series is one of the largest to report the safety,
feasibility and outcomes after LRC for GBC. While a laparo-
scopic cholecystectomy is one of the most commonly
performed minimally invasive procedures, laparoscopic
management of GBC has been relatively slow to develop. Tra-
ditionally, a suspicion of GBC was considered a contraindica-
tion for the laparoscopic approach,9 the main concern being
the high incidence of reported port site recurrence (0–
48%).10,11 In these reports, published in late 90s and in the
early 2000s, a laparoscopic cholecystectomy was done for sus-
pected benign pathology, with the plane of transection breach-
ing the cystic plate, and perhaps associated with GB
perforation in a significant number of cases.
Before adopting the minimally invasive approach for surgical
management of GBC, the important questions that need to be
addressed include the technical feasibility of performing an
adequate oncological resection, whether there is an increased
incidence of port-site metastases after LRC and whether the
long-term oncological outcomes are similar to that of an open
procedure.
With regards to the technical feasibility, the major compo-
nents of an LRC include a liver resection and lymphadenectomy.
The feasibility of a laparoscopic liver resection (both major and
minor hepatectomy) has been established.13 Similarly, studies
have demonstrated similar short- and long-term outcomes after
open and laparoscopic D2 lymphadenectomy for gastric can-
cer.14 In the present series, an R0 resection with adequate
lymphadenectomy could be accomplished in all the patients
without any gall bladder perforation and bile spillage.
The proposed mechanisms of port site recurrence are direct
and indirect implantation of tumour cells at the port sites,
during the laparoscopic procedure.15 Direct implantation of
tumour cells may occur from seeding of exfoliated malignant
cells during either forcible extraction of the tumor (specimen)
without a protective bag, either through a small wound or by
contact with instruments contaminated with tumour cells.
Indirect contamination is usually secondary to the pneumo-
peritoneum and occurs either by an ‘aerosol’ effect wherein
exfoliated tumour cells are disseminated to the port sites dur-
ing the turbulence of insufflation or by a ‘chimney’ effect
wherein the tumour cells are transferred to wound during
episodes of desufflation.16 The evidence favouring pneumoperi-
toneum (indirect implantation) as the cause of port site recur-
rence are occasional reports of port site recurrence in patients
who underwent laparoscopic surgery without tumour manipu-
lation and recurrence in ports other than the extraction
port.17–19 However, experimental studies using improved
tumour models (solid tumour models instead of intraperito-
neal cell culture lines) have shown that mechanical factors such
as surgical manipulation and tumour rupture may play a more
important role in the causation of port site recurrence and
pneumoperitoneum alone (indirect implantation) has a negligi-
ble effect.20 The experience with laparoscopic colorectal cancer
surgery demonstrated that with the use of appropriate preven-
tive measures the incidence of port site recurrence was approx-
imately 1.1%, which was comparable to open surgery.21,22 In
the present series, during a median (range) follow-up of 18
(6–34) months, none of the patients who underwent a laparo-
Table 2 Studies on a laparoscopic radical cholecystectomy for gallbladder cancer
Cho et al7 Gumbs et al8 Present series
Study period 2004–2007 2005–2011 2011–2013
No of patients 18 15 24
Inclusion criteria Primary GBC
(T1 and T2)
Primary GBC
(T1–3) and IGBC
Primary GBC
(T1–3)and IGBC
Inter-aorto caval
node sampling biopsy
No No Yes
Extent of liver resection GB with 2 mm
liver wedge
Segment
IVb & V
Segment IVb & V
Lymph node yield,
median, range
8 (4–21) 4a(1–11) 10 (4–31)
Port site recurrence – – –
a
Average lymph node yield.
HPB 2015, 17, 536–541 ª 2015 International Hepato-Pancreato-Biliary Association
HPB 539
scopic radical cholecystectomy developed a recurrence at the
port site. Thus, with proper surgical techniques such as mini-
mal tumour handling, avoidance of the bile spillage and use of
a protective bag for specimen extraction, recurrence at the port
site can be minimized.
The first prospective study on laparoscopic surgery for
suspected GBC included 30 patients selected based on a pre-
operative endoscopic ultrasound and intra-operative laparo-
scopic ultrasound done to rule out any liver invasion.7 All
patients underwent a laparoscopic cholecystectomy with a
2 mm liver wedge to avoid transecting through the cystic plate
and avoid bile spillage. Hepatoduodenal with a hepatic artery
lymphadenectomy was performed in 18 patients who had evi-
dence of malignancy on frozen section examination of a chole-
cystectomy specimen (Table 2). No additional hepatic resection
was performed in patients who had GBC on frozen section
examination. A limitation of this study was that it included a
very specific subgroup of patients with GBC with no liver infil-
tration. Also, although a laparoscopic hepatoduodenal and hepa-
tic artery lymph node clearance was done, only a 2 mm liver
wedge was resected along with the gall bladder. Recently, Gumbs
et al.8 reported their experience of minimally invasive surgery
for an extrapancreatic cholangiocarcinoma performed over a
period of 6 years in three different international centres. Of the
29 cases included in their multi-institutional study, 15 under-
went an LRC for GBC. The average lymph node yield in their
series was only four, which is less than what is recommended.8
The present series wherein 24 patients underwent LRC with a
median lymph node yield of 10 is one of the largest series to
report the feasibility of LRC for early (T1 and T2) and select
locally advanced (T3) GBC. At a median (range) follow-up of 18
(6–34) months none of the patients developed a port site recur-
rence. Similarly in the series reported by Cho et al.7 and Gumbs
et al.8, none of the patients had a port site recurrence during a
median follow-up of 18 and 23 months, respectively. As the
median reported time to port site recurrence is 6 months after
the index cholecystectomy, it is reasonable to assume that LRC
does not increase the incidence of port site recurrence, if ade-
quate preventive measures are taken.23 These reports also high-
light the fact that port site recurrence after a laparoscopic
cholecystectomy performed for unsuspected GBC cannot be
extrapolated to LRC as there are critical technical differences
between these two procedures. In the present series, none of the
patients had a positive cystic duct margin. However, if the cystic
duct margin is positive, a CBD excision should be performed.
The feasibility of laparoscopic CBD excision in GBC has been
reported in the literature.4
In the present series (and in the 2 previously reported
series), all patients underwent an R0 resection, and there was
no bile spillage. The mean and median lymph node yield in
the LRC group was 12.5 and 10, respectively, which was com-
parable to the lymph node yield in the ORC Group and those
reported in the other major ORC series.24,25 While one patient
(pT3N0) in the present series developed lymph nodal recur-
rence with jaundice at 14 months follow up, it does not appear
related to the laparoscopic approach as an R0 resection with
adequate lymph node yield (14 nodes) was achieved in that
patient. None of the patients with early GBC developed a
recurrence. Similarly, in the other series, none of the early
GBC patients developed a recurrence during a median follow-
up of 18 months in one series; and 2 patients with stage IIIB
disease developed recurrence at 3 and 20 months follow-up in
the other series.7,8 The reported recurrences after LRC were in
patients with stage III disease suggesting that the tumour biol-
ogy rather than the access route is the cause for recurrence.
The benefits of performing a laparoscopic resection include
accomplishing the procedure with similar radicality both in
terms of adequate liver resection and locoregional lymphaden-
ectomy with all the benefits of the minimal access approach
including less pain, early ambulation, decreased would-related
complications and a cosmetic scar. From the present series, it
is evident that with the careful patient selection and proper
surgical techniques such as minimal tumour handling, avoid-
ance of the bile spillage and the use of a protective bag for
specimen extraction, early oncological outcomes comparable to
the open procedure could be achieved and the benefits of a
minimal invasive procedure could be provided to the patients.
AS LRC is a technically complex procedure, it should be per-
formed only in centres with sufficient experience in advanced
laparoscopic hepatobiliary surgery. A limitation of the present
study is that the groups are not randomized and the compari-
son is with a matched group, which may have a potential for a
bias. While the present study has shown that early oncological
outcomes of LRC and ORC are comparable, randomized trials
with long-term follow up would be a definite answer to the
question of oncological equivalence. The results of the present
non-randomized retrospective comparative study will form the
basis for a future randomized trial.
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